丁丙诺啡
医学
国家数据库
慢性疼痛
骨科手术
普通外科
数据库
麻醉
类阿片
外科
物理疗法
内科学
计算机科学
受体
作者
Alexander B. Stone,Haoyan Zhong,Jashvant Poeran,Jiabin Liu,Crispiana Cozowicz,Alex Illescas,Stavros G. Memtsoudis
标识
DOI:10.1016/j.bja.2022.11.013
摘要
Editor—Buprenorphine is a partial μ-opioid receptor agonist that is increasingly used for treatment of chronic pain.1,2 Buprenorphine has been reported to be associated with less respiratory depression and fewer adverse effects compared with full μ-opioid receptor agonists.2,3 Acute pain management of patients taking buprenorphine perioperatively can pose a challenge, and there is debate as to whether to continue buprenorphine in the perioperative period.4 The American Society of Regional Anesthesia and Pain Medicine recommends that patients prescribed buprenorphine for opioid use disorder be maintained on treatment during the perioperative period if possible, and be returned to their preoperative dose as soon as possible if treatment is interrupted.
科研通智能强力驱动
Strongly Powered by AbleSci AI